A successful combination of upadacitinib and guselkumab in refractory psoriasis and psoriatic arthritis: A case report

Monotherapy may not be sufficient for the complete control of the psoriatic disease in selected patients. In refractory patients, combining two drugs with different mechanisms of action may result in improved efficacy. Data regarding the combination of biologics and Janus kinase inhibitors are lacki...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofia Antolini, Giorgia Scagliosi, Olta Veliaj, Antonio Carletto, Elena Fracassi, Paolo Gisondi
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X251352160
Tags: Add Tag
No Tags, Be the first to tag this record!